Conference Coverage

VIDEO: Management of difficult-to-treat IBD cases


 

EXPERT ANALYSIS FROM DIGESTIVE DISEASES: NEW ADVANCES

PHILADELPHIA – The lack of evidence-based management strategies for the treatment of difficult inflammatory bowel disease cases, such as with Crohn’s disease, can lead to confusion for some clinicians.

Dr. Mark T. Osterman, assistant professor of medicine at the University of Pennsylvania, Philadelphia, discusses when to use antibiotics in Crohn’s disease and when to consider antibiotics in combination with draining fistulae. He also discusses available pharmacotherapies, and the value of bowel rest.

“The best treatment of all for difficult inflammatory bowel disease is aggressive and early, so that the condition doesn’t go from bad to worse,” Dr. Osterman said.

The video was recorded at this year’s meeting of Digestive Diseases: New Advances, a meeting held by Global Academy for Medical Education and Rutgers, the State University of New Jersey. Global Academy and this news organization are owned by the same company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

VIDEO: Rectal indomethacin does not prevent pancreatitis post ERCP
MDedge Internal Medicine
VIDEO: Anesthesia services during colonoscopy increase risk of near-term complications
MDedge Internal Medicine
VIDEO: Newer MRI hardware, software significantly better at detecting pancreatic cysts
MDedge Internal Medicine
Privacy measure inadvertently suppresses substance abuse data
MDedge Internal Medicine
Better control of asymptomatic C. difficile needed in communities
MDedge Internal Medicine
Mongersen could be an impressive new treatment for inflammatory bowel disease
MDedge Internal Medicine
Perfect storm brewing for price war in gastroenterology
MDedge Internal Medicine
Sulindac plus erlotinib reduces duodenal polyp burden
MDedge Internal Medicine
Statins inversely linked to colorectal cancer in patients with IBD
MDedge Internal Medicine
Risk of IBD doubled in hidradenitis suppurativa
MDedge Internal Medicine